4//SEC Filing
Chambers Michael Andrew 4
Accession 0000950170-25-037531
CIK 0000873303other
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 8:00 PM ET
Size
7.6 KB
Accession
0000950170-25-037531
Insider Transaction Report
Form 4
Chambers Michael Andrew
Director
Transactions
- Award
Common Stock
2025-03-10+2,383→ 10,660 total - Award
Stock Options (right to buy)
2025-03-10+4,792→ 4,792 totalExercise: $99.69From: 2026-03-10Exp: 2035-03-10→ Common Stock (4,792 underlying)
Holdings
- 284,034(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 10, 2026.
Documents
Issuer
Sarepta Therapeutics, Inc.
CIK 0000873303
Entity typeother
Related Parties
1- filerCIK 0001932527
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 8:00 PM ET
- Accepted
- Mar 11, 8:00 PM ET
- Size
- 7.6 KB